🕵️ Spyglass Pharma, Inc. ($SGP)
SEC insider & ownership activity, last 12 months · CIK 1778922 · every row links its SEC filing
Over the last 12 months insiders bought $221.5M with no open-market selling against it. RA Capital Management, L.P. bought $59.0M in discretionary trades (Feb). No red-flag 8-Ks in the window.
Insider flow
15 buyers, $221.5M (17 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 2 | $59.0M | 0 | – | Feb 9, 2026 |
| Scott D. Sandell | 1 | $15.0M | 0 | – | Feb 9, 2026 |
| Behbahani Ali | 1 | $15.0M | 0 | – | Feb 9, 2026 |
| Chang Carmen | 1 | $15.0M | 0 | – | Feb 9, 2026 |
| Edward T. Mathers | 1 | $15.0M | 0 | – | Feb 9, 2026 |
| Forest Baskett | 1 | $15.0M | 0 | – | Feb 9, 2026 |
| Anthony A. Florence, JR. | 1 | $15.0M | 0 | – | Feb 9, 2026 |
| Mohamad H. Makhzoumi | 1 | $15.0M | 0 | – | Feb 9, 2026 |
| Paul Walker | 1 | $15.0M | 0 | – | Feb 9, 2026 |
| New Enterprise Associates 17, L.P. | 1 | $15.0M | 0 | – | Feb 9, 2026 |
| Rick Yang | 1 | $15.0M | 0 | – | Feb 9, 2026 |
| Geoffrey B. Pardo | 1 | $5.0M | 0 | – | Feb 9, 2026 |
| Kirk G. Nielsen | 1 | $2.6M | 0 | – | Feb 9, 2026 |
| Vensana Capital I GP, LLC | 1 | $2.6M | 0 | – | Feb 9, 2026 |
| Khan Bilal Arshad | 2 | $2.2M | 0 | – | Feb 9, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 24.1% | 13D | Feb 9, 2026 | filing ↗ | |
| Peter Kolchinsky | 24.1% | 13D | Feb 9, 2026 | filing ↗ | |
| Rajeev Shah | 24.1% | 13D | Feb 9, 2026 | filing ↗ | |
| Scott D. Sandell | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| Ali Behbahani | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| Carmen Chang | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| Forest Baskett | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| Anthony A. Florence, JR. | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| Mohamad H. Makhzoumi | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| New Enterprise Associates 16, L.P. | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| NEA Partners 16, L.P. | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| NEA 16 GP, LLC | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| Paul Walker | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| New Enterprise Associates 17, L.P. | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| NEA Partners 17, L.P. | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| NEA 17 GP, LLC | 22.2% | 13D | Feb 9, 2026 | filing ↗ | |
| Edward T. Mathers | 18.1% | 13D | Feb 9, 2026 | filing ↗ | |
| Rick Yang | 18.1% | 13D | Feb 9, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 17.9% | 13D | Feb 9, 2026 | filing ↗ | |
| Kirk Nielsen | 9.9% | 13D | Feb 9, 2026 | filing ↗ | |
| Vensana Capital I GP, LLC | 9.9% | 13D | Feb 9, 2026 | filing ↗ | |
| Vensana Capital I, L.P. | 9.9% | 13D | Feb 9, 2026 | filing ↗ | |
| Peter Justin Klein | 9.9% | 13D | Feb 9, 2026 | filing ↗ | |
| Frank M. Sands | 7.8% | 13G | Feb 13, 2026 | filing ↗ | |
| Gilde Healthcare VG VI Management B.V. | 6.6% | 13D | Feb 9, 2026 | filing ↗ | |
| Cooperatieve Gilde Healthcare VG VI U.A. | 6.6% | 13D | Feb 9, 2026 | filing ↗ | |
| Manapouri B.v. | 6.6% | 13D | Feb 9, 2026 | filing ↗ | |
| Martemanshurk B.v. | 6.6% | 13D | Feb 9, 2026 | filing ↗ | |
| Gilde Healthcare Holding B.v. | 6.6% | 13D | Feb 9, 2026 | filing ↗ | |
| Sands Capital Life Sciences Pulse Fund Iii-Holdings, L.P. | 6.5% | 13G | Feb 13, 2026 | filing ↗ | |
| Srinivas Akkaraju | 6.3% | 13G | Feb 17, 2026 | filing ↗ | |
| RA Capital Nexus Fund III, L.P. | 6.2% | 13D | Feb 9, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Other events (8.01) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 5, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Feb 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 5, 2026 | filing ↗ |